Equity Capital Markets

Tenaya Therapeutics

03/25
|
$52.5 Million
Tenaya
Piper Sandler served as bookrunner for Tenaya Therapeutics on its CMFO
Sub-Type
CMFO
Sub-Sector
Biopharma